Multidrug-resistant Escherichia coli in Asia: epidemiology and management

References

• Pitout JD. Extraintestinal pathogenic escherichia coli: a combination of virulence with antibiotic resistance. Front Microbiol 2012;3:9
   PubMed Web of Science ®Google Scholar
• Qureshi ZA, Paterson DL, Peleg AY, et al. Clinical characteristics of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae in the era of CTX-M-type and KPC-type beta-lactamases. Clin Microbiol Infect 2012;18:887-93
   PubMed Web of Science ®Google Scholar
• Kuenzli E, Jaeger VK, Frei R, et al. High colonization rates of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli in Swiss travellers to South Asia- a prospective observational multicentre cohort study looking at epidemiology, microbiology and risk factors. BMC Infect Dis 2014;14:528
   PubMed Web of Science ®Google Scholar
• Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 2005;25:358-73
   PubMed Web of Science ®Google Scholar
• Frost LS, Leplae R, Summers AO, et al. Mobile genetic elements: the agents of open source evolution. Nat Rev Microbiol 2005;3:722-32
   PubMed Web of Science ®Google Scholar
• Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011;66:1-14
   PubMed Web of Science ®Google Scholar
• Canton R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006;9:466-75
   PubMed Web of Science ®Google Scholar
• Woodford N, Carattoli A, Karisik E, et al. Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother 2009;53:4472-82
   PubMed Web of Science ®Google Scholar
• Qureshi ZA, Doi Y. Escherichia coli sequence type 131: epidemiology and challenges in treatment. Expert Rev Anti Infect Ther 2014;12:597-609
   PubMed Web of Science ®Google Scholar
• Yong D, Toleman MA, Giske CG, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54
   PubMed Web of Science ®Google Scholar
• Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-61
   PubMed Web of Science ®Google Scholar
• Cai JC, Zhang R, Hu YY, et al. Emergence of Escherichia coli sequence type 131 isolates producing KPC-2 carbapenemase in China. Antimicrob Agents Chemother 2014;58:1146-52
   PubMed Web of Science ®Google Scholar
• Peirano G, Bradford PA, Kazmierczak KM, et al. Global incidence of carbapenemase-producing Escherichia coli ST131. Emerg Infect Dis 2014;20:1928-31
   PubMedGoogle Scholar
• ß-Lactamase Classification and Amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. Available from: www.lahey.org/Studies/.html
   Google Scholar
• Bush K, Jacoby GA. Updated functional classification of beta-lactamases. Antimicrob Agents Chemother 2010;54:969-76
   PubMed Web of Science ®Google Scholar
• Lahey hospital & medical center. Available from: www.lahey.org/Studies/temtable.asp
   Google Scholar
• Tzouvelekis LS, Bonomo RA. SHV-type beta-lactamases. Curr Pharm Des 1999;5:847-64
   PubMed Web of Science ®Google Scholar
• Jarlier V, Nicolas MH, Fournier G, et al. Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988;10:867-78
   PubMedGoogle Scholar
• Canton R, Gonzalez-Alba JM, Galan JC. CTX-M Enzymes: origin and Diffusion. Front Microbiol 2012;3:110
   PubMed Web of Science ®Google Scholar
• Karim A, Poirel L, Nagarajan S, et al. Plasmid-mediated extended-spectrum beta-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol Lett 2001;201:237-41
   PubMed Web of Science ®Google Scholar
• Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010;35:316-21
   PubMed Web of Science ®Google Scholar
• Coque TM, Novais A, Carattoli A, et al. Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. Emerg Infect Dis 2008;14:195-200
   PubMed Web of Science ®Google Scholar
• Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, et al. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008;61:273-81
   PubMed Web of Science ®Google Scholar
• Hu YY, Cai JC, Zhou HW, et al. Molecular typing of CTX-M-producing escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. Appl Environ Microbiol 2013;79:5988-96
   PubMed Web of Science ®Google Scholar
• Leflon-Guibout V, Blanco J, Amaqdouf K, et al. Absence of CTX-M enzymes but high prevalence of clones, including clone ST131, among fecal Escherichia coli isolates from healthy subjects living in the area of Paris, France. J Clin Microbiol 2008;46:3900-5
   PubMed Web of Science ®Google Scholar
• Johnson JR, Nicolas-Chanoine MH, DebRoy C, et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012;18:598-607
   PubMed Web of Science ®Google Scholar
• Sidjabat HE, Seah KY, Coleman L, et al. Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coli. Int J Antimicrob Agents 2014;44:203-8
   PubMedGoogle Scholar
• Poirel L, Potron A, Nordmann P. OXA-48-like carbapenemases: the phantom menace. J Antimicrob Chemother 2012;67:1597-606
   PubMed Web of Science ®Google Scholar
• Kim YA, Qureshi ZA, Adams-Haduch JM, et al. Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin Infect Dis 2012;55:224-31
   PubMedGoogle Scholar
• Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17:1791-8
   PubMed Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009;9:228-36
   PubMed Web of Science ®Google Scholar
• Wailan AM, Paterson DL. The spread and acquisition of NDM-1: a multifactorial problem. Expert Rev Anti Infect Ther 2014;12:91-115
   PubMed Web of Science ®Google Scholar
• Kumarasamy KK, Toleman MA, Walsh TR, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010;10:597-602
   PubMed Web of Science ®Google Scholar
• Sartor AL, Raza MW, Abbasi SA, et al. Molecular Epidemiology of NDM-1-Producing Enterobacteriaceae and Acinetobacter baumannii Isolates from Pakistan. Antimicrob Agents Chemother 2014;58:5589-93
   PubMedGoogle Scholar
• Sidjabat H, Nimmo GR, Walsh TR, et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase. Clin Infect Dis 2011;52:481-4
   PubMed Web of Science ®Google Scholar
• Albur M, Noel A, Bowker K, et al. Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae. Antimicrob Agents Chemother 2012;56:3441-3
   PubMed Web of Science ®Google Scholar
• Wang D, Chen J, Yang L, et al. Phenotypic and Enzymatic Comparative Analysis of the KPC Variants, KPC-2 and Its Recently Discovered Variant KPC-15. PLoS One 2014;9:e111491
   Google Scholar
• Hornsey M, Phee L, Wareham DW. A novel variant, NDM-5, of the New Delhi metallo-beta-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother 2011;55:5952-4
   PubMed Web of Science ®Google Scholar
• Nakano R, Nakano A, Hikosaka K, et al. First Report of Metallo-beta-Lactamase NDM-5 producing escherichia coli in Japan. Antimicrob Agents Chemother 2014;58(12):7611-12
   PubMedGoogle Scholar
• Rogers BA, Sidjabat HE, Silvey A, et al. Treatment options for new delhi metallo-beta-lactamase-harboring enterobacteriaceae. Microb Drug Resist 2013;19:100-3
   PubMed Web of Science ®Google Scholar
• Tada T, Miyoshi-Akiyama T, Dahal RK, et al. NDM-8 metallo-beta-lactamase in a multidrug-resistant Escherichia coli strain isolated in Nepal. Antimicrob Agents Chemother 2013;57:2394-6
   PubMedGoogle Scholar
• Williamson DA, Sidjabat HE, Freeman JT, et al. Identification and molecular characterisation of New Delhi metallo-beta-lactamase-1 (NDM-1)- and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. Int J Antimicrob Agents 2012;39:529-33
   PubMed Web of Science ®Google Scholar
• Tada T, Shrestha B, Miyoshi-Akiyama T, et al. NDM-12, a novel New Delhi metallo-beta-lactamase variant from a carbapenem-resistant Escherichia coli clinical isolate in Nepal. Antimicrob Agents Chemother 2014;58:6302-5
   PubMedGoogle Scholar
• Ma L, Siu LK, Lin JC, et al. Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan. BMC Infect Dis 2013;13:599
   PubMed Web of Science ®Google Scholar
• Hassan H, Abdalhamid B. Molecular characterization of extended-spectrum beta-lactamase producing Enterobacteriaceae in a Saudi Arabian tertiary hospital. J Infect Developing Ctries 2014;8:282-8
   PubMedGoogle Scholar
• Hussain A, Ranjan A, Nandanwar N, et al. Genotypic and phenotypic profiles of Escherichia coli isolates belonging to clinical ST131, clinical non-ST131 and faecal non-ST131 lineages from India. Antimicrob Agents Chemother 2014;58(12):7240-9
   PubMedGoogle Scholar
• Kim S, Sung JY, Cho HH, et al. Characterization of CTX-M-14 and CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae isolates from urine specimens in a tertiary-care hospital. J Microbiol Biotechnol 2014;24:765-70
   PubMedGoogle Scholar
• Li B, Sun JY, Liu QZ, et al. High prevalence of CTX-M beta-lactamases in faecal Escherichia coli strains from healthy humans in Fuzhou, China. Scand J Infect Dis 2011;43:170-4
   PubMed Web of Science ®Google Scholar
• Severin JA, Mertaniasih NM, Kuntaman K, et al. Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J Antimicrob Chemother 2010;65:465-9
   PubMedGoogle Scholar
• Zhao WD, Yan P, Guan HN, et al. Characterization of CTX-M-type extended-spectrum beta-lactamase in clinical clones of Escherichia coli in Southwest China. J Basic Microbiol 2014;54:247-52
   PubMedGoogle Scholar
• Netikul T, Sidjabat HE, Paterson DL, et al. Characterization of an IncN2-type blaNDM-1-carrying plasmid in Escherichia coli ST131 and Klebsiella pneumoniae ST11 and ST15 isolates in Thailand. J Antimicrob Chemother 2014;69(11):3161-3
   PubMed Web of Science ®Google Scholar
• Perry JD, Naqvi SH, Mirza IA, et al. Prevalence of faecal carriage of Enterobacteriaceae with NDM-1 carbapenemase at military hospitals in Pakistan, and evaluation of two chromogenic media. J Antimicrob Chemother 2011;66:2288-94
   PubMed Web of Science ®Google Scholar
• Teo J, Ngan G, Balm M, et al. Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals. Western Pac Surveill Response J 2012;3:19-24
   PubMedGoogle Scholar
• Islam MA, Talukdar PK, Hoque A, et al. Emergence of multidrug-resistant NDM-1-producing Gram-negative bacteria in Bangladesh. Eur J Clin Microbiol Infect Dis 2012;31:2593-600
   PubMedGoogle Scholar
• World Bank. Population Total. Retreived 8 November 2014
   Google Scholar
• Shen D, Winokur P, Jones RN. Characterization of extended spectrum beta-lactamase-producing Klebsiella pneumoniae from Beijing, China. Int J Antimicrob Agents 2001;18:185-8
   PubMedGoogle Scholar
• Xiong Z, Zhu D, Wang F, et al. Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China. Diagn Microbiol Infect Dis 2002;44:195-200
   PubMedGoogle Scholar
• Li CR, Li Y, Zhang PA. Dissemination and spread of CTX-M extended-spectrum beta-lactamases among clinical isolates of Klebsiella pneumoniae in central China. Int J Antimicrob Agents 2003;22:521-5
   PubMedGoogle Scholar
• Sheng WH, Badal RE, Hsueh PR, et al. Distribution of extended-spectrum beta-lactamases, AmpC beta-lactamases, and carbapenemases among Enterobacteriaceae isolates causing intra-abdominal infections in the Asia-Pacific region: results of the study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2013;57:2981-8
   PubMed Web of Science ®Google Scholar
• Xia S, Fan X, Huang Z, et al. Dominance of CTX-M-type extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli isolated from patients with community-onset and hospital-onset infection in China. PLoS One 2014;9:e100707
   PubMedGoogle Scholar
• Zhang L, Lu X, Zong Z. The emergence of blaCTX-M-15-carrying Escherichia coli of ST131 and new sequence types in Western China. Ann Clin Microbiol Antimicrob 2013;12:35
   PubMedGoogle Scholar
• Zong Z, Yu R. bla(CTX-M)-carrying Escherichia coli of the O25b ST131 clonal group have emerged in China. Diagn Microbiol Infect Dis 2011;69:228-31
   PubMedGoogle Scholar
• Sun Y, Zeng Z, Chen S, et al. High prevalence of bla(CTX-M) extended-spectrum beta-lactamase genes in Escherichia coli isolates from pets and emergence of CTX-M-64 in China. Clin Microb Infect 2010;16:1475-81
   Google Scholar
• Liu W, Chen L, Li H, et al. 2009;Novel CTX-M {beta}-lactamase genotype distribution and spread into multiple species of Enterobacteriaceae in Changsha, Southern China. J Antimicrob Chemother 2009;63:895-900
   PubMed Web of Science ®Google Scholar
• Ding H, Yang Y, Lu Q, et al. The prevalence of plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from five children’s hospitals in China. Eur J Clin Microbiol Infect Dis 2008;27:915-21
   PubMed Web of Science ®Google Scholar
• Han C, Yang Y, Wang M, et al. The prevalence of plasmid-mediated quinolone resistance determinants among clinical isolates of ESBL or AmpC-producing Escherichia coli from Chinese pediatric patients. Microbiol Immunol 2010;54:123-8
   PubMedGoogle Scholar
• Li Y, Li Q, Du Y, et al. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China. J Clin Microbiol 2008;46:1317-21
   PubMed Web of Science ®Google Scholar
• Wei ZQ, Du XX, Yu YS, et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007;51:763-5
   PubMed Web of Science ®Google Scholar
• Hu L, Zhong Q, Shang Y, et al. The prevalence of carbapenemase genes and plasmid-mediated quinolone resistance determinants in carbapenem-resistant Enterobacteriaceae from five teaching hospitals in central China. Epidemiol Infect 2014;142:1972-7
   PubMed Web of Science ®Google Scholar
• Qi Y, Wei Z, Ji S, et al. ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China. J Antimicrob Chemother 2011;66:307-12
   PubMed Web of Science ®Google Scholar
• Chen L, Hu H, Chavda KD, et al. Complete sequence of a KPC-producing IncN multidrug-resistant plasmid from an epidemic Escherichia coli sequence type 131 strain in China. Antimicrob Agents Chemother 2014;58:2422-5
   PubMedGoogle Scholar
• Li G, Wei Q, Wang Y, et al. Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China. Eur J Clin Microbiol Infect Dis 2011;30:575-80
   PubMed Web of Science ®Google Scholar
• Yang J, Chen Y, Jia X, et al. Dissemination and characterization of NDM-1-producing Acinetobacter pittii in an intensive care unit in China. Clin Microbiol Infect 2012;18:E506-13
   PubMed Web of Science ®Google Scholar
• Ho PL, Li Z, Lai EL, et al. Emergence of NDM-1-producing Enterobacteriaceae in China. J Antimicrob Chemother 2012;67:1553-5
   PubMed Web of Science ®Google Scholar
• Qin S, Fu Y, Zhang Q, et al. High incidence and endemic spread of NDM-1-positive enterobacteriaceae in henan province, China. Antimicrob Agents Chemother 2014;58:4275-82
   PubMed Web of Science ®Google Scholar
• Zhou G, Guo S, Luo Y, et al. NDM-1-producing strains, family Enterobacteriaceae, in hospital, Beijing, China. Emerg Infect Dis 2014;20:340-2
   PubMed Web of Science ®Google Scholar
• Ho PL, Yeung MK, Lo WU, et al. Predominance of pHK01-like incompatibility group FII plasmids encoding CTX-M-14 among extended-spectrum beta-lactamase-producing Escherichia coli in Hong Kong, 1996-2008. Diagn Microbiol Infect Dis 2012;73:182-6
   PubMed Web of Science ®Google Scholar
• Ho PL, Lo WU, Lai EL, et al. Escherichia coli O25b-ST131 is an important cause of antimicrobial-resistant infections in women with uncomplicated cystitis. J Antimicrob Chemother 2012;67:2534-5
   PubMedGoogle Scholar
• Ho PL, Lo WU, Yeung MK, et al. Complete sequencing of pNDM-HK encoding NDM-1 carbapenemase from a multidrug-resistant Escherichia coli strain isolated in Hong Kong. PLoS One 2011;6:e17989
   PubMed Web of Science ®Google Scholar
• Tsang KY, Luk S, Lo JY, et al. Hong Kong experiences the ’Ultimate superbug’: NDM-1 Enterobacteriaceae. Hong Kong Med J 2012;18:439-41
   PubMedGoogle Scholar
• Ho PL, Lo WU, Wong RC, et al. Complete sequencing of the FII plasmid pHK01, encoding CTX-M-14, and molecular analysis of its variants among Escherichia coli from Hong Kong. J Antimicrob Chemother 2011;66:752-6
   PubMed Web of Science ®Google Scholar
• Ye QH, Lau Y, Liang B, et al. Antimicrobial resistance, genotypic characterization and pulsed-field gel electrophoresis typing of extended spectrum beta-lactamases-producing clinical Escherichia coli strains in Macao, China. Chin Med J 2011;124:2701-7
   PubMedGoogle Scholar
• Lin CF, Hsu SK, Chen CH, et al. Genotypic detection and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a regional hospital in central Taiwan. J Med Microbiol 2010;59:665-71
   PubMedGoogle Scholar
• Shu JC, Chia JH, Kuo AJ, et al. A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol Infect 2010;138:253-63
   PubMedGoogle Scholar
• Chung HC, Lai CH, Lin JN, et al. Bacteremia caused by extended-spectrum-beta-lactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob Agents Chemother 2012;56:618-22
   PubMed Web of Science ®Google Scholar
• Chen CJ, Wu TL, Lu PL, et al. Closely Related NDM-1-Encoding Plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. PLoS One 2014;9:e104899
   PubMed Web of Science ®Google Scholar
• Yan JJ, Tsai LH, Wu JJ. Emergence of the IMP-8 metallo-beta-lactamase in the Escherichia coli ST131 clone in Taiwan. Int J Antimicrob Agents 2012;40:281-2
   PubMedGoogle Scholar
• Kao CY, Udval U, Wu HM, et al. First report of the prevalence of extended-spectrum beta-lactamase producing Escherichia coli in two Mongolian hospitals. Infect Genet Evol 2014;25:66-8
   PubMedGoogle Scholar
• Yokota S, Sato T, Okubo T, et al. Prevalence of fluoroquinolone-resistant Escherichia coli O25:H4-ST131 (CTX-M-15-nonproducing) strains isolated in Japan. Chemotherapy 2012;58:52-9
   PubMedGoogle Scholar
• Chong Y, Yakushiji H, Ito Y, et al. Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a long-term study from Japan. Eur J Clin Microbiol Infect Dis 2011;30:83-7
   PubMedGoogle Scholar
• Nakamura T, Komatsu M, Yamasaki K, et al. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum beta-lactamases from clinical samples in the Kinki Region of Japan. Am J Clin Pathol 2012;137:620-6
   PubMedGoogle Scholar
• Yaita K, Aoki K, Suzuki T, et al. Epidemiology of extended-spectrum beta-lactamase producing Escherichia coli in the stools of returning Japanese travelers, and the risk factors for colonization. PLoS One 2014;9:e98000
   Google Scholar
• Matsumura Y, Yamamoto M, Higuchi T, et al. Prevalence of plasmid-mediated AmpC beta-lactamase-producing Escherichia coli and spread of the ST131 clone among extended-spectrum beta-lactamase-producing E. coli in Japan. Int J Antimicrob Agents 2012;40:158-62
   PubMedGoogle Scholar
• Koyano S, Saito R, Nagai R, et al. Molecular characterization of carbapenemase-producing clinical isolates of Enterobacteriaceae in a teaching hospital, Japan. J Med Microbiol 2013;62:446-50
   PubMedGoogle Scholar
• Hayakawa K, Miyoshi-Akiyama T, Kirikae T, et al. Molecular and epidemiological characterization of IMP-type metallo-beta-lactamase-producing Enterobacter cloacae in a Large tertiary care hospital in Japan. Antimicrob Agents Chemother 2014;58:3441-50
   PubMedGoogle Scholar
• Yano H, Ogawa M, Endo S, et al. High frequency of IMP-6 among clinical isolates of metallo-beta-lactamase-producing Escherichia coli in Japan. Antimicrob Agents Chemother 2012;56:4554-5
   PubMedGoogle Scholar
• Mizuno Y, Yamaguchi T, Matsumoto T. A first case of New Delhi metallo-beta-lactamase-7 in an Escherichia coli ST648 isolate in Japan. J Infect Chemother 2014;20(12):814-16
   PubMedGoogle Scholar
• Yamamoto T, Takano T, Iwao Y, et al. Emergence of NDM-1-positive capsulated Escherichia coli with high resistance to serum killing in Japan. J Infect Chemother 2011;17:435-9
   PubMed Web of Science ®Google Scholar
• Saito R, Takahashi R, Sawabe E, et al. First report of KPC-2 Carbapenemase-producing Klebsiella pneumoniae in Japan. Antimicrob Agents Chemother 2014;58:2961-3
   PubMedGoogle Scholar
• Jeong SH, Bae IK, Kim D, et al. First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum beta-lactamases in Korea. Antimicrob Agents Chemother 2005;49:4809-10
   PubMedGoogle Scholar
• Kim J, Kwon Y, Pai H, et al. Survey of Klebsiella pneumoniae strains producing extended-spectrum beta-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol 1998;36:1446-9
   PubMed Web of Science ®Google Scholar
• Ryoo NH, Kim EC, Hong SG, et al. Dissemination of SHV-12 and CTX-M-type extended-spectrum beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae and emergence of GES-3 in Korea. J Antimicrob Chemother 2005;56:698-702
   PubMed Web of Science ®Google Scholar
• Kim J, Lim YM, Rheem I, et al. CTX-M and SHV-12 beta-lactamases are the most common extended-spectrum enzymes in clinical isolates of Escherichia coli and Klebsiella pneumoniae collected from 3 university hospitals within Korea. FEMS Microbiol Lett 2005;245:93-8
   PubMed Web of Science ®Google Scholar
• Song W, Lee H, Lee K, et al. CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 2009;58:261-6
   PubMedGoogle Scholar
• Park SH, Byun JH, Choi SM, et al. Molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli in the community and hospital in Korea: emergence of ST131 producing CTX-M-15. BMC Infect Dis 2012;12:149
   PubMed Web of Science ®Google Scholar
• Lee K, Lee M, Shin JH, et al. Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 2006;12:44-9
   PubMedGoogle Scholar
• Yoo JS, Byeon J, Yang J, et al. High prevalence of extended-spectrum beta-lactamases and plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae isolated from long-term care facilities in Korea. Diagn Microbiol Infect Dis 2010;67:261-5
   PubMedGoogle Scholar
• Yoo JS, Kim HM, Koo HS, et al. Nosocomial transmission of NDM-1-producing Escherichia coli ST101 in a Korean hospital. J Antimicrob Chemother 2013;68:2170-2
   PubMedGoogle Scholar
• Hong SK, Yong D, Kim K, et al. First outbreak of KPC-2-producing Klebsiella pneumoniae sequence type 258 in a hospital in South Korea. J Clin Microbiol 2013;51:3877-9
   PubMedGoogle Scholar
• Hawser SP, Bouchillon SK, Hoban DJ, et al. Emergence of high levels of extended-spectrum-beta-lactamase-producing gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother 2009;53:3280-4
   PubMed Web of Science ®Google Scholar
• Kaur N, Sharma S, Malhotra S, et al. Urinary tract infection: aetiology and antimicrobial resistance pattern in infants from a tertiary care hospital in northern India. J Clin Diagn Res 2014;8:DC01-3
   PubMedGoogle Scholar
• Roy S, Krishnan R, Mukherjee S, et al. Prevalence of ST131 virulence-associated strains among CTX-M-producing Escherichia coli in the gut of hospitalized neonates in India. Diagn Microbiol Infect Dis 2013;77:158-9
   PubMedGoogle Scholar
• Bora A, Hazarika NK, Shukla SK, et al. Prevalence of blaTEM, blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India. Indian J Pathol Microbiol 2014;57:249-54
   PubMedGoogle Scholar
• Mohamudha Parveen R, Manivannan S, Harish BN, et al. Study of CTX-M type of extended spectrum beta-lactamase among nosocomial isolates of escherichia coli and klebsiella pneumoniae in south India. Indian J Microbiol 2012;52:35-40
   PubMedGoogle Scholar
• Hussain A, Ewers C, Nandanwar N, et al. Multiresistant uropathogenic Escherichia coli from a region in India where urinary tract infections are endemic: genotypic and phenotypic characteristics of sequence type 131 isolates of the CTX-M-15 extended-spectrum-beta-lactamase-producing lineage. Antimicrob Agents Chemother 2012;56:6358-65
   PubMedGoogle Scholar
• Bhattacharya D, Thamizhmani R, Bhattacharya H, et al. Emergence of New Delhi metallo-beta-lactamase 1 (NDM-1) producing and multidrug resistant uropathogens causing urinary tract infections in Andaman Islands, India. Microb Drug Resist 2013;19:457-62
   PubMedGoogle Scholar
• Lascols C, Hackel M, Marshall SH, et al. Increasing prevalence and dissemination of NDM-1 metallo-beta-lactamase in India: data from the SMART study (2009). J Antimicrob Chemother 2011;66:1992-7
   PubMed Web of Science ®Google Scholar
• Roy S, Singh AK, Viswanathan R, et al. Transmission of imipenem resistance determinants during the course of an outbreak of NDM-1 Escherichia coli in a sick newborn care unit. J Antimicrob Chemother 2011;66:2773-80
   PubMed Web of Science ®Google Scholar
• Khajuria A, Praharaj AK, Kumar M, et al. Emergence of Escherichia coli, Co-Producing NDM-1 and OXA-48 Carbapenemases, in Urinary Isolates, at a tertiary care centre at central india. J Clin Diagn Res 2014;8:DC01-4
   PubMedGoogle Scholar
• Potron A, Poirel L, Verdavaine D, et al. Importation of KPC-2-producing Escherichia coli from India. J Antimicrob Chemother 2012;67:242-3
   PubMedGoogle Scholar
• Mirza SH, Salman M, Khurshid U, et al. CTX-M ESBL enzyme in Escherichia coli from urology patients in Rawalpindi, Pakistan. J Pak Med Assoc 2006;56:576-8
   PubMedGoogle Scholar
• Habeeb MA, Haque A, Iversen A, et al. Occurrence of virulence genes, 16S rRNA methylases, and plasmid-mediated quinolone resistance genes in CTX-M-producing Escherichia coli from Pakistan. Eur J Clin Microbiol Infect Dis 2014;33:399-409
   PubMedGoogle Scholar
• Hussain M, Hasan F, Shah AA, et al. Prevalence of class A and AmpC beta-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn J Infect Dis 2011;64:249-52
   PubMed Web of Science ®Google Scholar
• Day KM, Ali S, Mirza IA, et al. Prevalence and molecular characterization of Enterobacteriaceae producing NDM-1 carbapenemase at a military hospital in Pakistan and evaluation of two chromogenic media. Diagn Microbiol Infect Dis 2013;75:187-91
   PubMedGoogle Scholar
• Day KM, Salman M, Kazi B, et al. Prevalence of NDM-1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media. J Appl Microbiol 2013;114:1810-16
   PubMedGoogle Scholar
• Farzana R, Shamsuzzaman SM, Mamun KZ, et al. Antimicrobial susceptibility pattern of extended spectrum beta-lactamase producing gram-negative bacteria isolated from wound and urine in a tertiary care hospital, Dhaka City, Bangladesh. Southeast Asian J Trop Med Public Health 2013;44:96-103
   PubMedGoogle Scholar
• Lina TT, Khajanchi BK, Azmi IJ, et al. Phenotypic and Molecular Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Bangladesh. PLoS One 2014;9:e108735
   Google Scholar
• Islam MA, Nabi A, Rahman M, et al. Prevalence of faecal carriage of NDM-1-producing bacteria among patients with diarrhoea in Bangladesh. J Med Microbiol 2014;63:620-2
   PubMedGoogle Scholar
• Chander A, Shrestha CD. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. BMC Res Notes 2013;6:487
   PubMedGoogle Scholar
• Sharma A, Shrestha S, Upadhyay S, et al. Clinical and bacteriological profile of urinary tract infection in children at Nepal medical college teaching hospital. Nepal Med College J 2011;13:24-6
   PubMedGoogle Scholar
• Pradhan R, Shrestha U, Gautam SC, et al. Bloodstream infection among children presenting to a general hospital outpatient clinic in urban Nepal. PLoS One 2012;7:e47531
   Google Scholar
• Bell JM, Turnidge JD, Gales AC, et al. Prevalence of extended spectrum beta-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998-99). Diagn Microbiol Infect Dis 2002;42:193-8
   PubMedGoogle Scholar
• Koh TH, Wang GC, Sng LH, et al. CTX-M and plasmid-mediated AmpC-producing Enterobacteriaceae Singapore. Emerg Infect Dis 2004;10:1172-4
   PubMedGoogle Scholar
• Tan TY, Ng LS, He J, et al. CTX-M and ampC beta-lactamases contributing to increased prevalence of ceftriaxone-resistant Escherichia coli in Changi General Hospital, Singapore. Diagn Microbiol Infect Dis 2010;66:210-13
   PubMedGoogle Scholar
• Koh TH, Sng LH, Wang G, et al. Emerging problems with plasmid-mediated DHA and CMY AmpC beta-lactamases in Enterobacteriaceae in Singapore. Int J Antimicrob Agents 2007;30:278-80
   PubMedGoogle Scholar
• Koh TH, Cao D, Tee NW, et al. Escherichia coli with bla(IMP-8) in Singapore. Antimicrob Agents Chemother 2014;58:617
   PubMedGoogle Scholar
• Apisarnthanarak A, Kiratisin P, Saifon P, et al. Clinical and molecular epidemiology of community-onset, extended-spectrum beta-lactamase-producing Escherichia coli infections in Thailand: a case-case-control study. Am J Infect Control 2007;35:606-12
   PubMed Web of Science ®Google Scholar
• Kiratisin P, Apisarnthanarak A, Laesripa C, et al. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother 2008;52:2818-24
   PubMed Web of Science ®Google Scholar
• Singtohin S, Chanawong A, Lulitanond A, et al. CMY-2, CMY-8b, and DHA-1 plasmid-mediated AmpC beta-lactamases among clinical isolates of Escherichia coli and Klebsiella pneumoniae from a university hospital, Thailand. Diagn Microbiol Infect Dis 2010;68:271-7
   PubMedGoogle Scholar
• Rimrang B, Chanawong A, Lulitanond A, et al. Emergence of NDM-1- and IMP-14a-producing Enterobacteriaceae in Thailand. J Antimicrob Chemother 2012;67:2626-30
   PubMed Web of Science ®Google Scholar
• Ho WS, Balan G, Puthucheary S, et al. Prevalence and characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Escherichia coli from pediatric wards of a Malaysian hospital. Microb Drug Resist 2012;18:408-16
   PubMedGoogle Scholar
• Hashim R, Shukor S, Ahmad N. Phenotypic and genotypic characterization of carbapenemase producing Enterobacteriaceae. Asia-Pacific Congress of Clinical Microbiology and Infection, 26-29 November 2014. Kuala Lumpur
   Google Scholar
• Karuniawati A, Saharman YR, Lestari DC. Detection of carbapenemase encoding genes in Enterobacteriace, Pseudomonas aeruginosa, and Acinetobacter baumanii isolated from patients at Intensive Care Unit Cipto Mangunkusumo Hospital in 2011. Acta Med Indones 2013;45:101-6
   PubMedGoogle Scholar
• Johnson DM, Biedenbach DJ, Jones RN. In vitro evaluation of broad-spectrum beta-lactams in the philippines medical centers: role of fourth-generation cephalosporins. The philippines antimicrobial resistance study group. Diagn Microbiol Infect Dis 1999;35:291-7
   PubMedGoogle Scholar
• Tian GB, Garcia J, Adams-Haduch JM, et al. CTX-M as the predominant extended-spectrum beta-lactamases among Enterobacteriaceae in Manila, Philippines. J Antimicrob Chemother 2010;65:584-6
   PubMedGoogle Scholar
• Copur Cicek A, Saral A, Ozad Duzgun A, et al. Nationwide study of Escherichia coli producing extended-spectrum beta-lactamases TEM, SHV and CTX-M in Turkey. J Antibiot (Tokyo) 2013;66:647-50
   PubMedGoogle Scholar
• Yumuk Z, Afacan G, Nicolas-Chanoine MH, et al. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15. J Antimicrob Chemother 2008;62:284-8
   PubMed Web of Science ®Google Scholar
• Poirel L, Yilmaz M, Istanbullu A, et al. Spread of NDM-1-producing Enterobacteriaceae in a neonatal intensive care unit in Istanbul, Turkey. Antimicrob Agents Chemother 2014;58:2929-33
   PubMed Web of Science ®Google Scholar
• Kader AA, Kumar AK. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med J 2004;25:570-4
   PubMed Web of Science ®Google Scholar
• Kader AA, Angamuthu K. Extended-spectrum beta-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram-negative bacteria in a hospital in Eastern Province, Saudi Arabia. Saudi Med J 2005;26:956-9
   PubMed Web of Science ®Google Scholar
• Dortet L, Poirel L, Al Yaqoubi F, et al. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman. Clin Microbiol Infect 2012;18:E144-8
   PubMed Web of Science ®Google Scholar
• Zowawi HM, Sartor AL, Balkhy HH, et al. Molecular Characterization of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in the Countries of the Gulf Cooperation Council: dominance of OXA-48 and NDM Producers. Antimicrob Agents Chemother 2014;58:3085-90
   PubMed Web of Science ®Google Scholar
• Baroud M, Dandache I, Araj GF, et al. Underlying mechanisms of carbapenem resistance in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases. Int J Antimicrob Agents 2013;41:75-9
   PubMed Web of Science ®Google Scholar
• Johnson JR, Oswald E, O’Bryan TT, et al. Phylogenetic distribution of virulence-associated genes among Escherichia coli isolates associated with neonatal bacterial meningitis in the Netherlands. J Infect Dis 2002;185:774-84
   PubMed Web of Science ®Google Scholar
• Yun KW, Kim HY, Park HK, et al. Virulence factors of uropathogenic Escherichia coli of urinary tract infections and asymptomatic bacteriuria in children. J Microbiol Immunol Infect 2014;47:455-61
   PubMedGoogle Scholar
• Florea C, Usein CR, Condei M, et al. Virulence characteristics of Escherichia coli isolates from children with urinary tract infections. Roum Arch Microbiol Immunol 2007;66:41-3
   PubMedGoogle Scholar
• Sakran W, Smolkin V, Odetalla A, et al. Community-Acquired Urinary Tract Infection in Hospitalized Children: etiology and Antimicrobial Resistance. A Comparison Between First Episode and Recurrent Infection. Clin Pediatr (Phila) 2014. [Epub ahead of print]
   PubMedGoogle Scholar
• Simonsen KA, Anderson-Berry AL, Delair SF, et al. Early-onset neonatal sepsis. Clin Microbiol Rev 2014;27:21-47
   PubMed Web of Science ®Google Scholar
• Nagao M. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals. Clin Microbiol Infect 2013;19:852-8
   PubMedGoogle Scholar
• Kim B, Kim J, Seo MR, et al. Clinical characteristics of community-acquired acute pyelonephritis caused by ESBL-producing pathogens in South Korea. Infection 2013;41:603-12
   PubMedGoogle Scholar
• Lausch KR, Fuursted K, Larsen CS, et al. Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel: a cross-sectional study. Travel Med Infect Dis 2013;11:320-3
   PubMedGoogle Scholar
• Ko YJ, Moon HW, Hur M, et al. Fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Korean community and hospital settings. Infection 2013;41:9-13
   PubMedGoogle Scholar
• Geser N, Stephan R, Korczak BM, et al. Molecular identification of extended-spectrum-beta-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland. Antimicrob Agents Chemother 2012;56:1609-12
   PubMedGoogle Scholar
• Ho PL, Chan J, Lo WU, et al. Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals. J Appl Microbiol 2013;114:695-702
   PubMed Web of Science ®Google Scholar
• Ho PL, Chow KH, Lai EL, et al. Extensive dissemination of CTX-M-producing Escherichia coli with multidrug resistance to ‘critically important’ antibiotics among food animals in Hong Kong, 2008-10. J Antimicrob Chemother 2011;66:765-8
   PubMed Web of Science ®Google Scholar
• Tian GB, Wang HN, Zou LK, et al. Detection of CTX-M-15, CTX-M-22, and SHV-2 extended-spectrum beta-lactamases (ESBLs) in Escherichia coli fecal-sample isolates from pig farms in China. Foodborne Pathog Dis 2009;6:297-304
   PubMedGoogle Scholar
• Liu BT, Yang QE, Li L, et al. Dissemination and characterization of plasmids carrying oqxAB-bla CTX-M genes in Escherichia coli isolates from food-producing animals. PloS One 2013;8:e73947
   Google Scholar
• Zheng H, Zeng Z, Chen S, et al. Prevalence and characterisation of CTX-M beta-lactamases amongst Escherichia coli isolates from healthy food animals in China. Int J Antimicrob Agents 2012;39:305-10
   PubMed Web of Science ®Google Scholar
• Jiang HX, Tang D, Liu YH, et al. Prevalence and characteristics of beta-lactamase and plasmid-mediated quinolone resistance genes in Escherichia coli isolated from farmed fish in China. J Antimicrob Chemother 2012;67:2350-3
   PubMed Web of Science ®Google Scholar
• Rao L, Lv L, Zeng Z, et al. Increasing prevalence of extended-spectrum cephalosporin-resistant Escherichia coli in food animals and the diversity of CTX-M genotypes during 2003-2012. Vet Microbiol 2014;172:534-41
   PubMedGoogle Scholar
• Harada K, Nakai Y, Kataoka Y. Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 beta-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan. Microbiol Immunol 2012;56:480-5
   PubMedGoogle Scholar
• Kameyama M, Chuma T, Yabata J, et al. Prevalence and Epidemiological Relationship of CMY-2 AmpC beta-Lactamase and CTX-M extended-spectrum beta-lactamase-producing escherichia coli isolates from broiler Farms in Japan. J Vet Med Sci 2013;75(8):1009-15
   PubMedGoogle Scholar
• Harada K, Morimoto E, Kataoka Y, et al. Clonal spread of antimicrobial-resistant Escherichia coli isolates among pups in two kennels. Acta Vet Scand 2011;53:11
   PubMedGoogle Scholar
• Tamang MD, Nam HM, Gurung M, et al. Molecular characterization of CTX-M beta-lactamase and associated addiction systems in Escherichia coli circulating among cattle, farm workers, and the farm environment. Appl Environ Microbiol 2013;79:3898-905
   PubMed Web of Science ®Google Scholar
• Tamang MD, Nam HM, Kim SR, et al. Prevalence and molecular characterization of CTX-M beta-lactamase-producing Escherichia coli isolated from healthy swine and cattle. Foodborne Pathog Dis 2013;10:13-20
   PubMedGoogle Scholar
• World Economic Forum. Global Risks An Initiative of the Risk Response Network. In:Howell L, editor. Eight Edition. 2013. p. 28-35
   Google Scholar
• Kresken M, Pfeifer Y, Hafner D, et al. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum beta-lactamases and the role of fosfomycin. Int J Antimicrob Agents 2014;44:295-300
   PubMedGoogle Scholar
• Hsueh PR, Hoban DJ, Carmeli Y, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 2011;63:114-23
   PubMed Web of Science ®Google Scholar
• Ghartey JP, Smith BC, Chen Z, et al. Lactobacillus crispatus dominant vaginal microbiome is associated with inhibitory activity of female genital tract secretions against Escherichia coli. PLoS One 2014;9:e96659
   PubMed Web of Science ®Google Scholar
• Brumbaugh AR, Mobley HL. Preventing urinary tract infection: progress toward an effective Escherichia coli vaccine. Expert Rev Vaccines 2012;11:663-76
   PubMed Web of Science ®Google Scholar
• Ruppe E, Lixandru B, Cojocaru R, et al. Relative fecal abundance of extended-spectrum-beta-lactamase-producing Escherichia coli strains and their occurrence in urinary tract infections in women. Antimicrob Agents Chemother 2013;57:4512-17
   PubMed Web of Science ®Google Scholar
• Huttner B, Haustein T, Uckay I, et al. Decolonization of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother 2013;68:2375-82
   PubMed Web of Science ®Google Scholar
• Gronberg-Hernandez J, Sunden F, Connolly J, et al. Genetic control of the variable innate immune response to asymptomatic bacteriuria. PLoS One 2011;6:e28289
   Google Scholar
• Trivedi D, Jena PK, Seshadri S. Colicin E2 Expression in Lactobacillus brevis DT24, A Vaginal Probiotic Isolate, against Uropathogenic Escherichia coli. ISRN urology 2014;2014:869610
   PubMedGoogle Scholar
• Jeong HS, Bae IK, Shin JH, et al. Prevalence of plasmid-mediated quinolone resistance and its association with extended-spectrum beta-lactamase and AmpC beta-lactamase in Enterobacteriaceae. Korean J Lab Med 2011;31:257-64
   PubMedGoogle Scholar
• Jiang Y, Zhou Z, Qian Y, et al. Plasmid-mediated quinolone resistance determinants qnr and aac(6’)-Ib-cr in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in China. J Antimicrob Chemother 2008;61:1003-6
   PubMed Web of Science ®Google Scholar
• Yan JJ, Wu JJ, Ko WC, et al. Plasmid-mediated 16S rRNA methylases conferring high-level aminoglycoside resistance in Escherichia coli and Klebsiella pneumoniae isolates from two Taiwanese hospitals. J Antimicrob Chemother 2004;54:1007-12
   PubMed Web of Science ®Google Scholar
• Yang J, Ye L, Wang W, et al. Diverse prevalence of 16S rRNA methylase genes armA and rmtB amongst clinical multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolates. Int J Antimicrob Agents 2011;38:348-51
   PubMed Web of Science ®Google Scholar
• Cai JC, Zhou HW, Zhang R, et al. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother 2008;52:2014-18
   PubMed Web of Science ®Google Scholar
• Liu Z, Li W, Wang J, et al. Identification and characterization of the first Escherichia coli strain carrying NDM-1 gene in China. PLoS One 2013;8:e66666
   Google Scholar
• Wei Z, Yu T, Qi Y, et al. Coexistence of plasmid-mediated KPC-2 and IMP-4 carbapenemases in isolates of Klebsiella pneumoniae from China. J Antimicrob Chemother 2011;66:2670-1
   PubMedGoogle Scholar
• Kim JS, Kim J, Kim SJ, et al. Characterization of CTX-M-type extended-spectrum beta-lactamase-producing diarrheagenic Escherichia coli isolates in the Republic of Korea during 2008-2011. J Microbiol Biotechnol 2014;24:421-6
   PubMed Web of Science ®Google Scholar
• Nahid F, Khan AA, Rehman S, et al. Prevalence of metallo-beta-lactamase NDM-1-producing multi-drug resistant bacteria at two Pakistani hospitals and implications for public health. J Infect Public Health 2013;6:487-93
   PubMed Web of Science ®Google Scholar
• Talukdar PK, Rahman M, Rahman M, et al. Antimicrobial resistance, virulence factors and genetic diversity of Escherichia coli isolates from household water supply in Dhaka, Bangladesh. PloS One 2013;8:e61090
   PubMed Web of Science ®Google Scholar
• Xia E, Khong WX, Marimuthu K, et al. Draft Genome sequence of a multidrug-resistant New Delhi Metallo-beta-Lactamase-1 (NDM-1)-producing escherichia coli isolate obtained in Singapore. Genome Announc 2013;19(6):e01020-13
   Google Scholar
• Tian GB, Adams-Haduch JM, Bogdanovich T, et al. PME-1, an extended-spectrum beta-lactamase identified in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2011;55:2710-13
   PubMed Web of Science ®Google Scholar